Skip to main content
SpringerLink
Log in

Hepatologie — Teil 3: Affektionen der Lunge

Pulmonale Komplikationen einer Lebererkrankung sicher erkennen

  • fortbildung
  • Published:
Gastro-News Aims and scope

Das hepatopulmonale Syndrom, die portopulmonale Hypertonie und der hepatisch bedingte Hydrothorax sind Komplikationen bei Patienten mit einem chronischen Leberschaden. Das gemeinsame Leitsymptom ist Dyspnoe. Da häufig Aszites oder pulmonale Begleiterkrankungen als Ursache der Luftnot angenommen werden, erfolgt die Diagnose oft erst in einem fortgeschrittenen Stadium. Dies kann schwerwiegende Folgen für den Patienten haben: Zum einen wird häufig eine Therapie nicht zeitgerecht eingeleitet, was die Prognose des Patienten signifikant verschlechtern kann. Zum anderen wird eine verbesserte Chance auf eine Lebertransplantation durch die Vergabe von „Exception Points“ auf der Warteliste nicht wahrgenommen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Hoeper M.M., Ghofrani H.A., Gorenflo M., Grünig E., Rosenkranz S., Schranz D. Diagnostik und Therapie der pulmonalen Hypertonie Europäische Leitlinien 2009

    Google Scholar 

  2. Krowka MJ, Cortese DA. Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations. Chest 1994;105:1528–37

    Article  CAS  Google Scholar 

  3. Lange PA, Stoller JK. The hepatopulmonary syndrome. Ann Intern Med 1995; 122: 521–9

    Article  CAS  Google Scholar 

  4. Christian P. Hepatopulmonales Syndrom und portopulmonale Hypertonie Hepatitis more Ausgabe 2 - Juni 2014

  5. Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: Impact of liver transplantation. Hepatology 2005;41:1122–1129

    Article  Google Scholar 

  6. Mueller C, Schenk P. Hepatopulmonary syndrome. Wien Klin Wochenschr 1999; 111: 339–47

    Google Scholar 

  7. Schenk P, Fuhrmann V, Madl C, Funk G, Lehr S, Kandel O, Mueller C. Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut. 2002 Dec;51(6):853–9.

    Article  CAS  Google Scholar 

  8. Berthelot P, Walker JG, Sherlock S, Reid L. Arterial changes in the lungs in cirrhosis of the liver-lung spider naevi. N Engl J Med 1966; 274: 291–8.

    Article  CAS  Google Scholar 

  9. Davis HH, Schwartz DJ, Lefrak SS, Susman N, Schainker BA. Alveolar-capillary oxygen disequilibrium in hepatic cirrhosis. Chest 1978;73: 507–11.

    Article  Google Scholar 

  10. Cremona G, Higenbottam TW, Mayoral V, Alexander G, Demoncheaux E, Borland C, Roe P, Jones GJ. Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome. Eur Respir J 1995; 8: 1883–5.

    Article  CAS  Google Scholar 

  11. Rolla G, Brussino L, Colagrande P, Dutto L, Polizzi S, Scappaticci E, Bergerone S, Morello M, Marzano A, Martinasso G, Salizzoni M, Bucca C. Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis. Hepatology 1997; 26: 842–7

    Article  CAS  Google Scholar 

  12. Luo B, Liu L, Tang L, Zhang J, Stockard CR, Grizzle WE, Fallon MB. Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome. J Hepatol 2003; 38: 556–63.

    Article  CAS  Google Scholar 

  13. Zhang HY, Han DW, Wang XG, Zhao YC, Zhou X, Zhao HZ. Experimental study on the role of endotoxin in the development of hepatopulmonary syndrome. World J Gastroenterol. 2005;11:567–572

    Article  CAS  Google Scholar 

  14. Rabiller A, Nunes H, Lebrec D, Tazi KA, Wartski M, Dulmet E, Libert JM, Mougeot C, Moreau R, Mazmanian M, Humbert M, Herve P. Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am J Respir Crit Care Med 2002; 166: 514–7.

    Article  Google Scholar 

  15. Zhang J, Luo B, Tang L, et al. Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Gastroenterology, 2009;136:1070–1080

    Article  CAS  Google Scholar 

  16. Krowka MJ, Fallon MB, Kawut SM, Fuhrmann V, Heimbach JK, Ramsay MA, Sitbon O, Sokol RJ. International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension. Transplantation. 2016 Jul;100(7):1440–52

    Article  Google Scholar 

  17. Anel RM, Sheagren JN: Novel presentation and approach to management of hepatopulmonary syndrome with use of antimicrobial agents. Clin Infect Dis 2001; 10: E131–136. MEDLINE

    Article  Google Scholar 

  18. Kang SH, Lee YB, Lee JH, et al. Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy. Aliment Pharmacol Ther. 2017 Nov;46(9):845–855. doi: https://doi.org/10.1111/apt.14275. Epub 2017 Au

    Article  CAS  Google Scholar 

  19. Allgaier HP, Haag K, Ochs A, Hauenstein KH, Jeserich M, Krause T, Heilmann C, Gerok W, Rossle M. Hepato-pulmonary syndrome: successful treatment by transjugular intrahepatic portosystemic stentshunt (TIPS). J Hepatol 1995; 23: 102.

    Article  CAS  Google Scholar 

  20. Riegler JL, Lang KA, Johnson SP, Westerman JH. Transjugular intrahepatic portosystemic shunt improves oxygenation in hepatopulmonary syndrome. Gastroenterology 1995; 109: 978–83.

    Article  CAS  Google Scholar 

  21. Lasch HM, Fried MW, Zacks SL, Odell P, Johnson MW, Gerber DA, Sandhu FS, Fair JH, Shrestha R. Use of transjugular intrahepatic portosystemic shunt as a bridge to liver transplantation in a patient with severe hepatopulmonary syndrome. Liver Transpl 2001; 7: 147–9.

    Article  CAS  Google Scholar 

  22. Krowka MJ, Mandell MS, Ramsay MA, Kawut SM, Fallon MB, Manzarbeitia C, Pardo M, Marotta P, Uemoto S, Stoffel MP, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl. 2004;10:174–182.

    Article  Google Scholar 

  23. Aldenkortt Florence, Aldenkortt Marc, Caviezel Laurence, Waeber Jean Luc, Weber Anne, and Schiffer Eduardo Portopulmonary hypertension and hepatopulmonary syndrome World J Gastroenterol. 2014 Jul 7; 20(25): 8072–8081.

    Article  Google Scholar 

  24. Michelakis ED, Wilkins MR, Rabinovitch M. Emerging concepts and translational priorities in pulmonary arterial hypertension. Circulation. 2008;118:1486–1495.

    Article  Google Scholar 

  25. Schenk P, Müller C Das Hepatopulmonale Syndrom Journal für Gastroenterologische und Hepatologische Erkrankungen 2004; 2 (3), 38–46

    Google Scholar 

  26. Hoeper MM, Halank M, Marx C, Hoeffken G, Seyfarth HJ, Schauer J, Niedermeyer J, Winkler J. Bosentan therapy for portopulmonary hypertension, Eur Respir J. 2005 Mar;25(3):502–8.

    Article  CAS  Google Scholar 

  27. Reichenberger F, Voswinckel R, Steveling E et al (2006) Sildenafil treatment for portopulmonary hypertension. Eur Respir J 28(3):563–567

    Article  CAS  Google Scholar 

  28. Cardenas A, Kelleher T, Chopra S. Review article: hepatic hydrothorax. Aliment Pharmacol Ther. 2004 Aug 1;20(3):271–9.

    Article  CAS  Google Scholar 

  29. Yong LV, Guohong Han, Daiming Fan Portopulmonary hypertension Scandinavian Journal of Gastroenterology Volume 51, 2016 - Issue 7

    Google Scholar 

  30. Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet. 2004 May 1;363(9419):1461–8.

    Article  Google Scholar 

  31. Chen A, Ho YS, Tu YC, et al. Diaphragmatic defect as a cause of massive hydrothorax in cirrhosis of liver. J Clin Gastroenterol 1988;10:663–6.

    Article  CAS  Google Scholar 

  32. Emerson PA, Davies JH. Hydrothorax complicating ascites. Lancet 1995;268:487–8

    Google Scholar 

  33. Castellote J, Gornals J, Lopez C, et al. Acute tension hydrothorax: a lifethreatening complication of cirrhosis. J Clin Gastroenterol 2002;34:588–9.

    Article  Google Scholar 

  34. Xiol X, Castellvi JM, Guardiola J, et al. Spontaneous bacterial empyema in cirrhotic patients: a prospective study. Hepatology 1996;23:719–23

    Article  CAS  Google Scholar 

  35. Kinasewitz GT, Keddissi JI. Hepatic hydrothorax. Curr Opin Pulm Med 2003;9:261–5.

    Article  Google Scholar 

  36. Boyer T. Transjugular intrahepatic portosystemic shunt: current status. Gastroenterology 2003;124:1700–10.

    Article  Google Scholar 

  37. Alberts WM, Salem AJ, Solomon DA, et al. Hepatic hydrothorax. Cause and management Arch Intern Med. 1991;151:2353–8.

    Google Scholar 

  38. Bundesärztekammer, Richtlinien für die Wartelistenführung und Organvermittlungzur Lebertransplantation 2011

Download references

Author information

Authors and Affiliations

  1. Klinik für Gastroenterologie und Hepatologie, Universitätsklinikum Essen, Hufelandstraße 55, 45147, Essen, Deutschland

    Annemarie Wegehaupt (Ärztin Post-LTX-Ambulanz) &  Heiner Wedemeyer (Direktor)

Authors
  1. Annemarie Wegehaupt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Heiner Wedemeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Annemarie Wegehaupt.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wegehaupt, A., Wedemeyer, H. Pulmonale Komplikationen einer Lebererkrankung sicher erkennen. Gastro-News 6, 40–45 (2019). https://doi.org/10.1007/s15036-019-0600-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15036-019-0600-x

Search

Navigation